Results 151 to 160 of about 288,544 (208)
Some of the next articles are maybe not open access.

Related searches:

Emerging Drugs for the Treatment of Perennial Allergic Rhinitis

Expert Opinion on Emerging Drugs, 2016
Allergic rhinitis is a worldwide health problem, currently affecting up to 40% of the general population, and characterized by the following symptoms in a variable degree of severity and duration: nasal congestion/obstruction, rhinorrhea, itchy nose and/or eyes, and/or sneezing.
Giorgio Ciprandi   +2 more
exaly   +4 more sources

Emerging drugs for perennial allergic rhinitis

Expert Opinion on Emerging Drugs, 2012
Allergic rhinitis (AR) is a high-prevalence disease, sustained by an IgE-triggered reaction with histamine release, followed by an inflammatory response which involves cells, mediators, cytokines and adhesion molecules. According to its duration, AR can be either intermittent or persistent.
Passalacqua,G, Ciprandi,G
openaire   +2 more sources

Perennial Allergic Rhinitis

2018
Compared with seasonal allergic rhinitis (SAR), exposure to allergens on a year-around basis leads to persistent symptoms that can be associated with significant impairment of quality of life. As is the case with SAR, management of perennial allergic rhinitis (PAR) entails aeroallergen avoidance, pharmacotherapy, and in properly select cases allergen ...
Martin A. Smith, David M. Lang
openaire   +1 more source

Pathophysiology of perennial allergic rhinitis

Allergy, 1997
Allergic rhinitis involves an early phase, largely mediated through mast cells, and a late phase which involves cellular infiltration and mediator release. In the early phase, mast cells release mediators as a result of antigen cross‐linking adjacent immunoglobulin E molecules bound to mast cell surfaces.
openaire   +2 more sources

Perennial Allergic Rhinitis and Nasal Hyperreactivity

American Journal of Rhinology, 1998
This article focuses on the nose as an accessible organ for research purposes, exploring whether the nose can be used to study lower airway processes.
openaire   +3 more sources

Efficacy of montelukast for treating perennial allergic rhinitis

Allergy and Asthma Proceedings, 2007
Perennial allergic rhinitis (PAR) is a chronic inflammatory nasal condition in individuals exposed year-round to allergens. This was a double-blind study of 15- to 85-year-old patients randomly allocated to montelukast, 10 mg (n=630), placebo (n=613), or the positive control cetirizine, 10 mg (n=122) for 6 weeks.
George, Philip   +8 more
openaire   +2 more sources

Neuronal Plasticity in Persistent Perennial Allergic Rhinitis

Journal of Occupational and Environmental Medicine, 2005
Persistent perennial allergic rhinitis belongs to the most frequent diseases in occupational and environmental medicine. Because the innervation may play a role in the pathogenesis of the disease, the present study analyzed nasal mucosal nerve profiles.Neuropeptide-containing nerve fibers were examined using immunohistochemistry and related to ...
Axel, Fischer   +9 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy